Only twenty more days until spring folks! The family is so over winter, we're all hoping March comes in like a lamb and stays! How about you?
To usher in March, we have a collection of slides which offer SVR rates on both FDA approved and investigational HCV agents, including interferon-free regimens in late stage clinical trials. A few other topics touch on off-label use by combining two newly approved drugs, terminology used to determine treatment response and links to relevant information.
The slide-set is best viewed in full screen mode, please click here to begin.
Information is extracted from news articles, peer-reviewed journals, as well as liver meetings/conferences, and research manuscripts.
This is brilliant! I just wrote on the same issue, and it will post on Monday, but your post makes me drool. I have blog-envy!
ReplyDelete